Фармацевтика

Arrowhead pharmaceuticals ceo stresses dual r&d and commercial focus

Arrowhead Pharmaceuticals highlighted its ongoing transition toward commercial operations while maintaining a strong research and development core during a recent industry conference.

Inovio Pharmaceuticals reviews Q1 results and INO-3107 FDA status

14 мая 2026 Сообщено ИИ

Inovio Pharmaceuticals held its first-quarter 2026 earnings call on May 13 to discuss financial results for the period ended March 31 and provide updates on its DNA medicines platform.

Здоровье

Semaglutide shows strong weight loss results for adults over 65

Бизнес

Acadia Pharmaceuticals publishes 2026 Q1 earnings slide deck

Африка

Egypt's industry minister meets pharma chamber to boost growth, exports

Biontech закроет почти все производственные площадки в Германии

Немецкая биотехнологическая компания Biontech планирует сократить до 1860 рабочих мест в Германии. Компания закроет несколько производственных площадок и прекратит выпуск вакцины от Covid в стране до конца года. В Германии останутся только административные офисы.

Pharco Pharmaceuticals plans EGP 1.5bn investments for production and export expansion

4 мая 2026 Сообщено ИИ

Pharco Pharmaceuticals plans to invest around EGP 1.5bn next year, up from about EGP 1.15bn in 2025, to expand production capacity and strengthen its presence in domestic and export markets, Chairperson Sherine Helmy said. The company is prioritising improvements in product quality alongside expansion and diversification of production lines.

Африка